Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk
Status:
NOT_YET_RECRUITING
Trial end date:
2030-12-30
Target enrollment:
Participant gender:
Summary
This study is a prospective, multicenter randomized controlled study. Additional fecal screening for Hp-specific SNP mutation sites on top of routine Hp testing may improve the identification of people at high risk for gastric cancer, and the treatment of eradication interventions in high-risk groups can significantly reduce the incidence or risk of progression of gastric cancer.